Re: Coronavirus
 

Re: Coronavirus
 

French company has announced it will give Britain priority access to its vaccine rather than France.

A French start-up has received an order from the UK for 40 million doses of its vaccine this week – with London to now be given priority access to the jabs over Paris and the rest of the EU. The vaccine is expected to be in the UK by June this year but may not be available in France until 2022. President and Chief Business Officer of biotech company Valneva, Franck Grimaud, has estimated that the first vaccines will be delivered to the UK as soon as medical trials are complete, which he believes will be as early as June 2021.

However, vaccines are only likely to be available to the EU by approximately the beginning of 2022, even though the company is based in Saint-Herblain, Pays de la Loire, France.

The Council President of the Pays de la Loire region has angrily blamed French President Emmanuel Macron for a missed opportunity to provide the vaccine to local people.


https://www.express.co.uk/news/world...lneva-jabs-spt

Re: Coronavirus
 

Would that happen to be their facility in Livingston?

Re: Coronavirus
 

I read a few weeks ago that medics were being so careful with the vials when drawing vaccine into the syringe that yield was higher than expected. Can’t find the link now, but it suggests that the pressure to find arms to inject has been there from very early on. I’m not sure it’s fairly categorised as a short cut though. Russia commencing wide-scale use of the Sputnik-V vaccine on the basis of stage 2 trials is a short cut.

---------- Post added at 16:40 ---------- Previous post was at 16:36 ----------

It is the Livingston facility, which has benefited from a government development grant as well as a thumping big order. Meanwhile the EU still hasn’t ordered anything from them. The French media, and regional politicians, are not happy.

https://www.bbc.co.uk/news/live/uk-5...ost_type=share

Re: Coronavirus
 

Re: Coronavirus
 

We should push for a day of 1 million vaccinations given how well it's going. Make it a competition.

Re: Coronavirus
 

Such a publicity stunt would almost certainly involve delaying vaccines to allow them to accumulate to that level. Or increasing capacity to issue them immediately upon arrival but being unable to vaccinate at that level across 7 days - on a weekly basis there's about 3 days worth at that level until at least June*. *if we trust the leaked Scottish Government data.

Re: Coronavirus
 

Then sent to Solna in Sweden for filling and exported from there. ;)

Re: Coronavirus
 

I suspect Damian’s tongue was firmly lodged in his cheek at that point. ;)

We don’t need any publicity stunts, we’re already outstripping the entire world, on a per capita basis, with the exceptions of Israel, because its signed up with Pfizer for a population scale survey in exchange for rapid supply, and a couple of the Gulf states which China is using to try to garner some good PR for its Sinopharm product.

---------- Post added at 17:19 ---------- Previous post was at 17:11 ----------

The AZ vaccine was initially bottled within the EU, which is probably what Von Der Lying was using as a pretext to insinuate that AZ was exporting product from the EU to fulfil UK orders. Since the Wrexham filling plant opened, we have had a complete domestic supply chain.

After the massive PR own goal last week, it’s very unlikely the EU would attempt to intercept drug products made in the UK, to fulfil a UK order, on the pretext that it had been bottled in the EU. However, it will be a few months before the Valneva product begins to enter the UK vaccination programme and if things do start to deteriorate further in the EU the UK government has already demonstrated its willingness to intervene to ensure there is adequate protection against UK supplies being purloined (which is how AstraZeneca came to be producing the Oxford vaccine in the first place).

Re: Coronavirus
 

EU vaccine war: Now Netherlands bans Oxford jab for over-65s as EU turns on UK firm


https://www.express.co.uk/news/polit...-65s-UK-latest

In a letter to health minister Hugo de Jonge, the advisory body also claimed people with a troubled immune system should not receive the Oxford-produced jab. Their recommendation follows a growing list of European regulators that have recommended against using doses of the Anglo-Swedish firm’s vaccine in the older population. It comes despite the EU’s drug watchdog, the European Medicines Agency, giving it the green light for use in all adults across the bloc.

Re: Coronavirus
 

EU member states are now behaving like children who, when told they can’t have something, start claiming they never wanted it anyway because it’s crap.

Re: Coronavirus
 

Will there be any older people left in the EU by the time this tantrum is over:shrug:

Re: Coronavirus
 

As said before, let them crack on. We’ll be done in a few months and they won’t be anywhere near.

And when turns out that the AZ is perfectly good for the over 65’s, they’ll just look stupid.

Re: Coronavirus
 

They're committing to put it into the arms where it's proven to work. Not sure why that's child like.

---------- Post added at 21:33 ---------- Previous post was at 21:32 ----------

The proof is indeed in the pudding.

Re: Coronavirus
 

I've been reading a bit about this and it's fascinating.

We didn't just place an order for 40 million vaccines, we placed an order for 40 million MORE vaccines from this company. Altogether it makes this vaccine, from a hitherto smaller company, our joint biggest vaccine alongside the Oxford one. https://www.bbc.co.uk/news/health-55887264

One of the successes of our vaccine rollout so far hasn't just been that we got orders in quickly and in large numbers but that the ones we ordered provided to be successful. Now that could have just been luck, we were always likely to back the Oxford one for example, and Pfizer are a huge company.

But the fact we've invested so much money in a small French company based in Nantes of all places suggests someone was paying close attention to the various candidates. If this vaccine is effective, and the order of an additional 40 million along with production ramping up in Scotland suggests they think it is, then we've got more than enough vaccines to cover everyone in the U.K more than once.

I would be very interested to see how the U.K identified this company in particular and why they placed more orders for their vaccine than any other apart from the Oxford one.